mRNA Vaccines Boost Cancer Survival
Groundbreaking research reveals that COVID-19 mRNA vaccines dramatically boost survival rates for patients with advanced lung and skin cancers receiving immunotherapy, potentially revolutionizing oncology care. This unexpected synergy appears to prime the immune system, transforming resistant tumors into immunotherapy-ready targets and suggesting a future where widely available mRNA vaccines could enhance cancer treatment.